Skip to main content

Year: 2023

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene

TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray PowderTING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray PowderTARRYTOWN, N.Y., Nov. 24, 2023 (GLOBE NEWSWIRE) — Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder to the consumer level. A recent review by our manufacturer and their third-party lab found that samples from two lots of the product contained elevated levels of benzene. While benzene is not an ingredient in any Ting® Antifungal Spray products, the review showed that unexpected levels of benzene came from the propellant that sprays the product out of the can. Importantly, no other lots of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal...

Continue reading

Global Mofy Metaverse Limited and ELLE CHINA, ELLE MEN CHINA Unite for a Dynamic Partnership, Redefining the Art of Advertising

Beijing, CHINA, Nov. 24, 2023 (GLOBE NEWSWIRE) — Global Mofy Metaverse Limited (the “Company” or “Global Mofy Metaverse”) (NASDAQ: GMM), a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry, today announced the Company and ELLE CHINA, ELLE MEN CHINA have forged a long-term partnership, embarking on an eagerly anticipated collaboration that promises mutual promotional benefits and an array of exciting projects in the realm of advertising and beyond. As part of this collaboration, ELLE MEN CHINA will provide Global Mofy Metaverse with a stable and influential platform for publicity, including avenues such as video channels and websites. These platforms will grant Global Mofy Metaverse invaluable exposure, enabling the dissemination...

Continue reading

Safety Shot Continues Scientific Development with Double-Blind Placebo-Controlled Trial Designed to Assess the Effects of Safety Shot on Blood and Breath Alcohol Levels

Topline data expected Q1 2024 Safety Shot is designed to make you feel good faster by reducing blood alcohol levels and improving clarity A double-blinded, placebo controlled, clinical trial designed to compare the effects of Safety shot on blood and breath alcohol levels is underway.JUPITER, FL, Nov. 24, 2023 (GLOBE NEWSWIRE) — Safety Shot, Inc. (Nasdaq: SHOT) today announced that a clinical trial to measure the effects of Safety Shot on blood and breath alcohol has commenced. Safety Shot is the first patented beverage that helps people feel better faster by reducing blood alcohol content and boosting clarity. Created by industry experts and validated by research, Safety Shot is a nutraceutical functional beverage that accelerates the body’s break-down of alcohol while aiding in recovery and rehydration. While there are many...

Continue reading

NurExone Reports Third Quarter 2023 Financial Results and Provides Corporate Update

TORONTO and HAIFA, Israel, Nov. 24, 2023 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (the “Company” or “NurExone”), a pioneering biotechnology company, released a corporate update and reported financial results for the quarter ended September 30, 2023. “I am pleased to report that we have reached a new pivotal point for our proprietary ExoPTEN drug, primarily in advancing our United States Food and Drug Administration regulatory strategy and the commercialization of our exosome-based technology portfolio,” said Dr. Lior Shaltiel, CEO of NurExone. “Most notably, we have received Orphan-Drug Designation and completed our Pre- Investigational New Drug meeting with the United States Food and Drug Administration for our ExoPTEN drug, which potentially expedites the process of launching our first ExoTherapy...

Continue reading

Black Friday and Cyber Monday: Get the Mudra Band for Apple Watch with Exclusive Holiday Offer!

Celebrate the future of gesture control– Shop Now at: www.mudra-band.com  YOKNEAM ILLIT, ISRAEL, Nov. 24, 2023 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (“Wearable Devices” or the “Company”), a technology growth company specializing in AI-powered touchless sensing wearables, is excited to announce a special Black Friday and Cyber Monday offer for its highly anticipated Mudra Band for Apple Watch, available now for orders at www.mudra-band.com. This innovative accessory, designed to revolutionize the way we interact with our Apple devices, is offered at an exclusive unbeatable price for the holiday shopping weekend.   The Mudra Band is an AI-powered aftermarket accessory that connects to the Apple Watch and uses wrist neural signals to translate movement intent into digital command. Unleash the full potential...

Continue reading

New Hope for Children: SciSparc’s patented CBD- Enhanced Solution for Autism Spectrum Disorder

TEL AVIV, Israel, Nov. 24, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare disease of the central nervous system, has initiated a clinical trial using its proprietary therapy, SCI-210, at Soroka Medical Center, Israel, targeting Autism Spectrum Disorder (ASD) symptoms in children. SciSparc’s novel SCI-210 therapy is not only a medication based on CBD; it is also a unique combination of cannabidiol (CBD) and SciSparc’s proprietary Palmitoylethanolamide, aimed to ease the symptoms of ASD. How will it work? Over a period of 20 weeks, the trial will enroll 60 participants between the ages of 5-18 years old to scientifically measure how SCI-210 compares...

Continue reading

Rogers Sugar Seeks Mediation in Ongoing Effort to Reach Fair Collective Agreement with Workers at Vancouver Refinery

VANCOUVER, British Columbia, Nov. 24, 2023 (GLOBE NEWSWIRE) — Rogers Sugar Inc. (the “Company” or “Rogers Sugar”) (TSX: RSI) today announced that it has applied to the British Columbia Labour Relations Board for mediation to reach a fair collective agreement with the Public and Private Workers of Canada (PPWC) Local 8 representing workers at the Company’s Vancouver refinery, and that the union has accepted mediation. The Company provided the following statement: “Rogers Sugar looks forward to the opportunity to work constructively with the union toward a fair collective agreement that will return our Vancouver plant to full sugar production as soon as possible. We remain fully committed to engaging in discussions aimed at finding a solution that works for the Company and for employees, and one that supports customers for the short...

Continue reading

Society Pass Inc (Nasdaq: SOPA) Granted Extension until 20 May 2024 to Regain Compliance with Nasdaq Listing Rules

NEW YORK, Nov. 24, 2023 (GLOBE NEWSWIRE) — Society Pass Inc. (Nasdaq: SOPA) (“SoPa” or the “Company”), Southeast Asia’s (SEA) next generation, data-driven, loyalty, fintech and e-commerce ecosystem announces that it has received an extension until 20 May 2024 to regain compliance with NASDAQ Listing Rules. The NASDAQ extension letter was filed in a Form 8-K with the U.S. Securities and Exchange Commission (“SEC”) on 22 November 2023. Click Here (on SEC website) to view Form 8-K. NASDAQ determined that SOPA is eligible for an additional 180 calendar day period, or until 20 May 2024, to regain compliance with NASDAQ’s minimum $1.00 per share bid price requirement, as set forth in NASDAQ Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”). This determination is pursuant to the discretionary authority granted to...

Continue reading

Wearable Devices Establishes U.S. Offices in Silicon Valley Expanding North American Presence

The Company, through its subsidiary, intends to foster stronger partner relations for its neural input technology and extend its market presence for the Mudra Band YOKNEAM ILLIT, ISRAEL, Nov. 24, 2023 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in AI-powered touchless sensing wearables, is excited to announce that its subsidiary has established a new U.S. office in Redwood City, California, less than thirty miles south of San Francisco. The new location is expected to enhance the Company’s market presence and partner relations while ushering in a significant chapter of growth and development. With offices located in the heart of Silicon Valley, the Company is poised to significantly strengthen its local presence by providing a dedicated...

Continue reading

CITIC Offshore Helicopter and Lilium partner to launch eVTOL Network in China’s Greater Bay Area

COHC and Lilium to jointly launch services in China using Lilium’s revolutionary eVTOL jet SHENZEN, China, Nov. 24, 2023 (GLOBE NEWSWIRE) — Lilium (NASDAQ: LILM), developer of the first all-electric vertical take-off and landing (eVTOL) jet, and CITIC Offshore Helicopter Co., Ltd (COHC), China’s sole helicopter port pilotage provider — today announced the signing of a Memorandum of Understanding (“MoU”) that will allow the two companies to strategically collaborate on the establish of an eVTOL operation network in China, starting with the Greater Bay Area. As part of the agreement, Lilium and COHC will work together to develop services in the region based on market demand, and eventually offer regular eVTOL services. This will initially commence in the Greater Bay Area, with additional planned service across the Guangdong-Hong...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.